Psyence Biomedical (PBM) Shares Outstanding (Diluted Average) (2023 - 2025)

Psyence Biomedical's Shares Outstanding (Diluted Average) history runs 3 years deep, the most recent figure standing at $1.5 billion for Q3 2025.

• In Q3 2025, Shares Outstanding (Diluted Average) rose 4165.72% year-over-year to $1.5 billion; the TTM figure through Sep 2025 stood at $1.5 billion (up 4165.72% YoY), while the FY2024 annual figure was $586490.0, down 98.81% from the prior year.
• Shares Outstanding (Diluted Average) was $1.5 billion for Q3 2025 at Psyence Biomedical, up from $34.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $1.5 billion in Q3 2025 to a low of $586490.0 in Q1 2024.
• Historically, Shares Outstanding (Diluted Average) has averaged $391.6 million across 3 years, with a median of $42.1 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) slumped 98.81% in 2024, then soared 4165.72% in 2025.
• A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $49.4 million in 2023, then retreated by 29.75% to $34.7 million in 2024, then jumped by 4165.72% to $1.5 billion in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $1.5 billion (Q3 2025), $34.7 million (Q3 2024), and $586490.0 (Q1 2024), per Business Quant data.